AsttraZeneca Pharmaceuticals LP 2025-05-28 Health serious FDA
Health · FDA · Recall #FDA-D-0444-2025
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation,… Recall
Issued May 28, 2025 · AsttraZeneca Pharmaceuticals LP
In May 2025, AsttraZeneca Pharmaceuticals LP recalled the Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective delivery system
What you should do
- 1 Stop using Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact AsttraZeneca Pharmaceuticals LP to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- AsttraZeneca Pharmaceuticals LP
- Category
- Health
- Recall date
- May 28, 2025
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0444-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- AsttraZeneca Pharmaceuticals LP has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.